| scholarly article | Q13442814 |
| P819 | ADS bibcode | 2014PLoSO...988226M |
| P356 | DOI | 10.1371/JOURNAL.PONE.0088226 |
| P932 | PMC publication ID | 3914967 |
| P698 | PubMed publication ID | 24505439 |
| P5875 | ResearchGate publication ID | 260127587 |
| P50 | author | Kevin M. Flanigan | Q41827189 |
| P2093 | author name string | Rui Xu | |
| Ajit Varki | |||
| Joe N Kornegay | |||
| Paul T Martin | |||
| Kumaran Chandrasekharan | |||
| Marybeth Camboni | |||
| Jonathan Okerblom | |||
| Bethannie Golden | |||
| P2860 | cites work | Utrophin-dystrophin-deficient mice as a model for Duchenne muscular dystrophy | Q24310537 |
| A mutation in human CMP-sialic acid hydroxylase occurred after the Homo-Pan divergence | Q24317040 | ||
| Immunization with the SDPM1 peptide lowers amyloid plaque burden and improves cognitive function in the APPswePSEN1(A246E) transgenic mouse model of Alzheimer's disease | Q24599108 | ||
| Short telomeres and stem cell exhaustion model Duchenne muscular dystrophy in mdx/mTR mice | Q24633931 | ||
| Colloquium paper: uniquely human evolution of sialic acid genetics and biology | Q24634579 | ||
| Human uptake and incorporation of an immunogenic nonhuman dietary sialic acid | Q24683362 | ||
| Molecular cloning of cytidine monophospho-N-acetylneuraminic acid hydroxylase. Regulation of species- and tissue-specific expression of N-glycolylneuraminic acid | Q28293297 | ||
| Monoclonal antibodies specific for T cell-associated carbohydrate determinants react with human blood group antigens CAD and SDA | Q28338541 | ||
| X chromosome-linked muscular dystrophy (mdx) in the mouse | Q28589078 | ||
| Dystrophin: the protein product of the Duchenne muscular dystrophy locus | Q29618077 | ||
| Complete cloning of the duchenne muscular dystrophy (DMD) cDNA and preliminary genomic organization of the DMD gene in normal and affected individuals | Q30050310 | ||
| An intronic LINE-1 element insertion in the dystrophin gene aborts dystrophin expression and results in Duchenne-like muscular dystrophy in the corgi breed | Q30497616 | ||
| N-glycolylneuraminic acid deficiency in mice: implications for human biology and evolution | Q30500850 | ||
| Deletion of the dystrophin muscle promoter in feline muscular dystrophy | Q72608176 | ||
| Skeletal and cardiac myopathies in mice lacking utrophin and dystrophin: a model for Duchenne muscular dystrophy | Q73677664 | ||
| The cranial sartorius muscle undergoes true hypertrophy in dogs with golden retriever muscular dystrophy | Q73755155 | ||
| Contraction force generated by tarsal joint flexion and extension in dogs with golden retriever muscular dystrophy | Q78212609 | ||
| Severe muscular dystrophy in mice that lack dystrophin and alpha7 integrin | Q83309941 | ||
| Tarsal joint contracture in dogs with golden retriever muscular dystrophy | Q44864009 | ||
| Contraction tension and kinetics of the peroneus longus muscle in golden retriever muscular dystrophy | Q44864300 | ||
| Clinical electromyographic studies of canine X-linked muscular dystrophy | Q44924465 | ||
| Effects of prednisone in canine muscular dystrophy | Q45093355 | ||
| Overexpression of the CT GalNAc transferase in skeletal muscle alters myofiber growth, neuromuscular structure, and laminin expression. | Q45973809 | ||
| Disrupted mechanical stability of the dystrophin-glycoprotein complex causes severe muscular dystrophy in sarcospan transgenic mice | Q46530689 | ||
| Interspecies comparison of muscle gangliosides by two-dimensional thin-layer chromatography | Q46559682 | ||
| LARGE can functionally bypass alpha-dystroglycan glycosylation defects in distinct congenital muscular dystrophies. | Q47375901 | ||
| The homologue of the Duchenne locus is defective in X-linked muscular dystrophy of dogs | Q59051983 | ||
| An error in dystrophin mRNA processing in golden retriever muscular dystrophy, an animal homologue of Duchenne muscular dystrophy | Q59416437 | ||
| Dystrophin deficiency causes lethal muscle hypertrophy in cats | Q68020670 | ||
| Mouse liver cytidine-5'-monophosphate-N-acetylneuraminic acid hydroxylase. Catalytic function and regulation | Q68127155 | ||
| Functional modifications of cytotoxic T-lymphocyte T200 glycoprotein recognized by monoclonal antibodies | Q69382238 | ||
| Novel antigenic determinants of the T200 glycoprotein expressed preferentially by activated cytotoxic T lymphocytes | Q69383686 | ||
| The molecular basis of muscular dystrophy in the mdx mouse: a point mutation | Q69514522 | ||
| Myofiber injury and regeneration in a canine homologue of Duchenne muscular dystrophy. | Q32122092 | ||
| Overexpression of the cytotoxic T cell GalNAc transferase in skeletal muscle inhibits muscular dystrophy in mdx mice | Q34025748 | ||
| Novel mechanism for the generation of human xeno-autoantibodies against the nonhuman sialic acid N-glycolylneuraminic acid | Q34044438 | ||
| Loss of N-glycolylneuraminic acid in humans: Mechanisms, consequences, and implications for hominid evolution | Q34109076 | ||
| A Human-Specific Deletion in Mouse Cmah Increases Disease Severity in the mdx Model of Duchenne Muscular Dystrophy | Q34175938 | ||
| Sarcospan-dependent Akt activation is required for utrophin expression and muscle regeneration | Q34284175 | ||
| Mechanism of uptake and incorporation of the non-human sialic acid N-glycolylneuraminic acid into human cells | Q34370155 | ||
| Randomized, double-blind six-month trial of prednisone in Duchenne's muscular dystrophy | Q34501945 | ||
| Severe cardiomyopathy in mice lacking dystrophin and MyoD | Q34801223 | ||
| Sarcospan reduces dystrophic pathology: stabilization of the utrophin-glycoprotein complex | Q34871548 | ||
| A sialylated glycan microarray reveals novel interactions of modified sialic acids with proteins and viruses. | Q35213210 | ||
| Postnatal overexpression of the CT GalNAc transferase inhibits muscular dystrophy in mdx mice without altering muscle growth or neuromuscular development: evidence for a utrophin-independent mechanism | Q35867446 | ||
| Overexpression of the cytotoxic T cell (CT) carbohydrate inhibits muscular dystrophy in the dyW mouse model of congenital muscular dystrophy 1A. | Q35928246 | ||
| Canine and feline models of human inherited muscle diseases | Q36031704 | ||
| Molecular, cellular, and pharmacological therapies for Duchenne/Becker muscular dystrophies. | Q36143635 | ||
| Metabolism of vertebrate amino sugars with N-glycolyl groups: mechanisms underlying gastrointestinal incorporation of the non-human sialic acid xeno-autoantigen N-glycolylneuraminic acid | Q36217161 | ||
| Role of extracellular matrix proteins and their receptors in the development of the vertebrate neuromuscular junction | Q36321503 | ||
| Mechanisms of disease: congenital muscular dystrophies-glycosylation takes center stage | Q36577280 | ||
| Diversity in cell surface sialic acid presentations: implications for biology and disease | Q36882467 | ||
| N-Glycolylneuraminic acid deficiency worsens cardiac and skeletal muscle pathophysiology in α-sarcoglycan-deficient mice | Q36900455 | ||
| Diversity in specificity, abundance, and composition of anti-Neu5Gc antibodies in normal humans: potential implications for disease | Q36981219 | ||
| Overexpression of Galgt2 in skeletal muscle prevents injury resulting from eccentric contractions in both mdx and wild-type mice | Q37139061 | ||
| Overexpression of Galgt2 reduces dystrophic pathology in the skeletal muscles of alpha sarcoglycan-deficient mice | Q37257159 | ||
| The synaptic CT carbohydrate modulates binding and expression of extracellular matrix proteins in skeletal muscle: Partial dependence on utrophin | Q37361308 | ||
| Mammalian animal models for Duchenne muscular dystrophy | Q37393140 | ||
| Canine models of Duchenne muscular dystrophy and their use in therapeutic strategies | Q37548291 | ||
| Dystroglycanopathies: coming into focus | Q37852376 | ||
| Characterization of a rat liver Golgi sulphotransferase responsible for the 6-O-sulphation of N-acetylglucosamine residues in beta-linkage to mannose: role in assembly of sialyl-galactosyl-N-acetylglucosamine 6-sulphate sequence of N-linked oligosac | Q38352657 | ||
| Canine and feline parvoviruses preferentially recognize the non-human cell surface sialic acid N-glycolylneuraminic acid | Q40053564 | ||
| Definition of pre- and postsynaptic forms of the CT carbohydrate antigen at the neuromuscular junction: ubiquitous expression of the CT antigens and the CT GalNAc transferase in mouse tissues | Q40676930 | ||
| N-acetyllactosamine and the CT carbohydrate antigen mediate agrin-dependent activation of MuSK and acetylcholine receptor clustering in skeletal muscle | Q40874394 | ||
| Distinct contributions of Galgt1 and Galgt2 to carbohydrate expression and function at the mouse neuromuscular junction | Q41267697 | ||
| Molecular cloning of a murine N-acetylgalactosamine transferase cDNA that determines expression of the T lymphocyte-specific CT oligosaccharide differentiation antigen | Q41466937 | ||
| Distinct structures and functions of related pre- and postsynaptic carbohydrates at the mammalian neuromuscular junction | Q41644137 | ||
| Post-translational disruption of dystroglycan-ligand interactions in congenital muscular dystrophies | Q42524150 | ||
| Muscular dystrophy in a litter of golden retriever dogs | Q44032308 | ||
| Eccentric contraction injury in dystrophic canine muscle | Q44209525 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 2 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | cytotoxicity | Q246181 |
| P304 | page(s) | e88226 | |
| P577 | publication date | 2014-01-01 | |
| P1433 | published in | PLOS One | Q564954 |
| P1476 | title | A comparative study of N-glycolylneuraminic acid (Neu5Gc) and cytotoxic T cell (CT) carbohydrate expression in normal and dystrophin-deficient dog and human skeletal muscle | |
| P478 | volume | 9 |
| Q35097359 | A role for Galgt1 in skeletal muscle regeneration |
| Q39250748 | Biochemical, Cellular, Physiological, and Pathological Consequences of Human Loss of N-Glycolylneuraminic Acid. |
| Q49220622 | Increased Number of Circulating CD8/CD26 T Cells in the Blood of Duchenne Muscular Dystrophy Patients Is Associated with Augmented Binding of Adenosine Deaminase and Higher Muscular Strength Scores. |
| Q28077544 | Sialic acids as link to Japanese scientists |
| Q36105761 | The immune system in Duchenne muscular dystrophy: Friend or foe. |
Search more.